David Linetsky - 02 Feb 2023 Form 4 Insider Report for Phreesia, Inc. (PHR)

Role: SVP, Life Sciences
Signature: /s/ Allison Hoffman by Power of Attorney for David Linetsky
Issuer symbol: PHR
Transactions as of: 02 Feb 2023
Net transactions value: -$449,989
Form type: 4
Filing time: 06 Feb 2023, 15:32:02 UTC
Previous filing: 18 Jan 2023
Next filing: 20 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHR	Common Stock	Sale	$449,989	-11,378	-5.2%	$39.55	205,489	02 Feb 2023	Direct	F1, F2
holding	PHR	Common Stock						5,583	02 Feb 2023	By spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.